Brian Herts, MD
Body ImagingAbdominal ImagingDiagnostic Radiology
Highlights
Age Groups Seen
- Child
- Adolescent
- Adult
Languages
- English
Gender
MaleAbout Brian Herts
Biography
Brian R. Herts, MD, was born in New York City. He has been on staff at Cleveland Clinic for more than 25 years. Currently the medical director of CT (computed tomography) Imaging Services for the Imaging Institute, he served as the Section Head of Abdominal Imaging in the Imaging Institute for 13 years. He holds a joint appointment with the Glickman Urological Institute and the Taussig Cancer Institute. He is a Professor of Radiology at the Cleveland Clinic Lerner College of Medicine at Case.
Dr. Herts is board-certified in diagnostic radiology with varied clinical interests including diagnosis of diseases of the genitourinary and gastrointestinal tracts. Special interests include diagnosis of kidney tumors and 3-dimensional imaging for surgical planning in transplantation and kidney cancer.
A frequent lecturer at national medical meetings, Dr. Herts has authored more than 90 peer-reviewed scientific papers and seven book chapters.
Education & Board Certifications
Education
- Residency: New York University Medical Center, 1992
- Internship: Lankenau Hospital, 1988
- Medical Education: University of Pennsylvania School of Medicine, 1987
- Undergraduate: Brown University, 1982
Board Certifications
- Diagnostic Radiology: American Board of Radiology, 1992
Awards
- Named \"Top doctors\" by Cleveland Magazine, 2015, 2016, 2017
- Named one of the region's \"Top Doctors\" by Northern Ohio Live Magazine, June 2007 and July 2008 (Castle-Connolly, ltd, peer nomination).
Professional Memberships
Innovations & Patents
Dr. Herts pioneered the use of volume-rendered imaging techniques for 3-dimensional CT surgical planning of partial nephrectomy with Dr. Andrew Novick, former Chair of the Glickman Urological and Kidney Institute.
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-10-06, Dr. Herts has reported the financial relationships with the companies listed below.
Fiduciary Role. Dr. Herts serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:
- AI Metrics
Consulting and/or Speaking. Dr. Herts receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Grail Bio
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.